DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE was reported 35666 times

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATAPLEXY 162 0.1143
1 PRE-EXISTING CONDITION IMPROVED 645 0.1032
2 PRODUCT ADMINISTRATION INTERRUPTED 650 0.0827
3 ASTHMA EXERCISE INDUCED 24 0.0690
4 PERIODIC LIMB MOVEMENT DISORDER 24 0.0652
5 SLEEP-RELATED EATING DISORDER 59 0.0630
6 SLEEP PARALYSIS 88 0.0599
7 NARCOLEPSY 107 0.0566
8 PERINATAL DEPRESSION 24 0.0532
9 MANUFACTURING ISSUE 24 0.0516
10 ABNORMAL SLEEP-RELATED EVENT 63 0.0477
11 SLEEP ATTACKS 22 0.0462
12 PARASOMNIA 33 0.0459
13 SOMNAMBULISM 278 0.0423
14 ATTENTION DEFICIT HYPERACTIVITY DISORDER 178 0.0422
15 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 57 0.0422
16 EHLERS-DANLOS SYNDROME 19 0.0409
17 ENURESIS 162 0.0401
18 SUBSTANCE USE 62 0.0397
19 SNORING 147 0.0388
20 OBSTRUCTIVE SLEEP APNOEA SYNDROME 56 0.0384
21 DISSOCIATION 255 0.0332
22 SLEEP APNOEA SYNDROME 632 0.0331
23 HANGOVER 103 0.0293
24 JOB DISSATISFACTION 19 0.0292
25 THYROTOXIC CRISIS 32 0.0281
26 TERMINAL INSOMNIA 46 0.0260
27 SUDDEN ONSET OF SLEEP 36 0.0259
28 CHOROIDAL EFFUSION 20 0.0249
29 POST-TRAUMATIC STRESS DISORDER 155 0.0231
30 GENERALISED ANXIETY DISORDER 34 0.0231
31 SLEEP TALKING 39 0.0230
32 FEELING DRUNK 165 0.0222
33 MAST CELL ACTIVATION SYNDROME 30 0.0214
34 MOANING 23 0.0202
35 TACHYPHRENIA 69 0.0199
36 BINGE EATING 21 0.0195
37 ABNORMAL UTERINE BLEEDING 49 0.0191
38 GAMBLING DISORDER 51 0.0189
39 INITIAL INSOMNIA 192 0.0187
40 COMPLEX REGIONAL PAIN SYNDROME 27 0.0183
41 MAJOR DEPRESSION 133 0.0182
42 DRUG TOLERANCE 91 0.0180
43 BIPOLAR DISORDER 186 0.0171
44 NASAL SEPTUM DEVIATION 33 0.0169
45 GASTRIC BYPASS 36 0.0165
46 BRUXISM 85 0.0157
47 BRAIN FOG 233 0.0149
48 MENTAL FATIGUE 22 0.0147
49 COMPULSIVE SHOPPING 30 0.0146
50 MOTION SICKNESS 28 0.0145
51 CERVICAL SPINAL STENOSIS 25 0.0145
52 HYPOVITAMINOSIS 19 0.0143
53 LIBIDO INCREASED 29 0.0143
54 ALCOHOL ABUSE 38 0.0142
55 SEIZURE LIKE PHENOMENA 24 0.0141
56 ENDOMETRIOSIS 66 0.0138
57 OBSESSIVE-COMPULSIVE DISORDER 109 0.0136
58 DRUG TITRATION ERROR 34 0.0132
59 DRUG DIVERSION 81 0.0131
60 THERAPEUTIC PRODUCT EFFECT VARIABLE 50 0.0129
61 BACTERIAL VAGINOSIS 20 0.0128
62 SLEEP DEFICIT 27 0.0128
63 BIPOLAR I DISORDER 28 0.0128
64 SEDATION 334 0.0127
65 EDUCATIONAL PROBLEM 21 0.0126
66 HYSTERECTOMY 109 0.0126
67 HUNGER 175 0.0126
68 EMOTIONAL POVERTY 22 0.0125
69 DRUG SCREEN NEGATIVE 22 0.0125
70 THERAPEUTIC RESPONSE UNEXPECTED 560 0.0125
71 PRODUCT SUBSTITUTION ISSUE 714 0.0124
72 RESTLESS LEGS SYNDROME 225 0.0124
73 AUTONOMIC NERVOUS SYSTEM IMBALANCE 36 0.0123
74 HYPOPNOEA 42 0.0121
75 ESSENTIAL HYPERTENSION 22 0.0120
76 AUTOIMMUNE THYROIDITIS 44 0.0116
77 SURGERY 674 0.0115
78 SUSPECTED PRODUCT QUALITY ISSUE 21 0.0115
79 MEDICAL PROCEDURE 19 0.0114
80 DISTURBANCE IN ATTENTION 616 0.0114
81 SLEEP TERROR 48 0.0114
82 LYME DISEASE 38 0.0114
83 CRANIOCEREBRAL INJURY 34 0.0112
84 NOCTURIA 135 0.0111
85 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 23 0.0111
86 HYPERTONIC BLADDER 32 0.0111
87 FOREIGN BODY IN REPRODUCTIVE TRACT 96 0.0107
88 PARANOIA 185 0.0107
89 PANIC DISORDER 41 0.0106
90 SHOULDER OPERATION 45 0.0105
91 INTENTIONAL DOSE OMISSION 295 0.0103
92 NECK SURGERY 24 0.0103
93 MIDDLE INSOMNIA 192 0.0103
94 DENTAL CARE 19 0.0103
95 ENDODONTIC PROCEDURE 26 0.0102
96 POOR QUALITY SLEEP 220 0.0102
97 DENTAL OPERATION 25 0.0101
98 HORMONE LEVEL ABNORMAL 49 0.0100
99 VITAMIN D DEFICIENCY 97 0.0099
100 EYE CONTUSION 21 0.0099
101 TIC 54 0.0099
102 CONCUSSION 76 0.0098
103 FEELING JITTERY 186 0.0098
104 TEMPOROMANDIBULAR JOINT SYNDROME 26 0.0097
105 TONGUE BITING 20 0.0097
106 SPINAL FUSION SURGERY 39 0.0096
107 MIGRAINE WITH AURA 26 0.0096
108 CLUMSINESS 26 0.0095
109 INTERVERTEBRAL DISC DEGENERATION 88 0.0095
110 SEASONAL ALLERGY 134 0.0095
111 PANIC ATTACK 340 0.0093
112 MENOPAUSE 24 0.0093
113 FEELING OF DESPAIR 43 0.0092
114 EUPHORIC MOOD 94 0.0092
115 SUICIDAL IDEATION 825 0.0090
116 APATHY 131 0.0090
117 ORAL SURGERY 21 0.0090
118 THINKING ABNORMAL 167 0.0090
119 LOSS OF EMPLOYMENT 27 0.0089
120 VITAMIN D DECREASED 76 0.0089
121 NECK INJURY 26 0.0089
122 INSURANCE ISSUE 133 0.0087
123 WRONG DOSE 21 0.0087
124 OBESITY 137 0.0086
125 LOGORRHOEA 30 0.0085
126 CARTILAGE INJURY 21 0.0085
127 DYSPAREUNIA 39 0.0085
128 PRODUCT FORMULATION ISSUE 56 0.0085
129 ANORGASMIA 23 0.0085
130 REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE 30 0.0084
131 DISABILITY 166 0.0084
132 RADICULOPATHY 22 0.0083
133 DEPRESSION 1896 0.0083
134 FIBROMYALGIA 202 0.0083
135 SPINAL STENOSIS 34 0.0082
136 ANGLE CLOSURE GLAUCOMA 21 0.0082
137 UNEVALUABLE EVENT 621 0.0082
138 EMBEDDED DEVICE 81 0.0082
139 PRODUCT TASTE ABNORMAL 110 0.0081
140 FOOT OPERATION 40 0.0081
141 ANGER 273 0.0081
142 IMPULSIVE BEHAVIOUR 30 0.0080
143 CARPAL TUNNEL SYNDROME 111 0.0079
144 INFUSION SITE PRURITUS 25 0.0079
145 IRRITABILITY 475 0.0079
146 MIGRAINE 753 0.0079
147 ANIMAL BITE 21 0.0079
148 YAWNING 21 0.0079
149 ANXIETY 2214 0.0078
150 PRODUCT AVAILABILITY ISSUE 177 0.0078
151 DENTAL CARIES 85 0.0077
152 PHARYNGITIS STREPTOCOCCAL 83 0.0077
153 PARANASAL SINUS DISCOMFORT 29 0.0077
154 MUSCLE TIGHTNESS 124 0.0076
155 INTERVERTEBRAL DISC PROTRUSION 167 0.0076
156 DRUG EFFECT LESS THAN EXPECTED 113 0.0076
157 CRYING 276 0.0076
158 AFFECTIVE DISORDER 59 0.0075
159 MENISCUS INJURY 46 0.0075
160 PLANTAR FASCIITIS 25 0.0074
161 FRUSTRATION TOLERANCE DECREASED 60 0.0074
162 SCOLIOSIS 46 0.0074
163 IMPAIRED GASTRIC EMPTYING 101 0.0074
164 SOMNOLENCE 1482 0.0074
165 IMPAIRED DRIVING ABILITY 83 0.0073
166 COMPLICATION OF DEVICE REMOVAL 132 0.0073
167 EMOTIONAL DISORDER 225 0.0073
168 ALCOHOLISM 31 0.0072
169 FOOD ALLERGY 55 0.0071
170 GLUCOSE TOLERANCE IMPAIRED 42 0.0071
171 MANIA 115 0.0070
172 FACIAL BONES FRACTURE 25 0.0069
173 APNOEA 54 0.0069
174 ROAD TRAFFIC ACCIDENT 290 0.0069
175 KNEE OPERATION 68 0.0069
176 FEELING ABNORMAL 1656 0.0069
177 NEURALGIA 168 0.0069
178 MOOD SWINGS 220 0.0069
179 NEPHROLITHIASIS 315 0.0069
180 DRUG SCREEN FALSE POSITIVE 19 0.0069
181 PRESCRIBED OVERDOSE 132 0.0068
182 INTENTIONAL PRODUCT USE ISSUE 597 0.0068
183 THERAPEUTIC RESPONSE CHANGED 43 0.0068
184 DECREASED INTEREST 40 0.0068
185 PERSONALITY CHANGE 63 0.0068
186 THYROID MASS 26 0.0068
187 SUBSTANCE ABUSE 55 0.0068
188 APPENDICECTOMY 24 0.0067
189 BACK INJURY 73 0.0067
190 VITAMIN B12 DEFICIENCY 27 0.0067
191 CHOLECYSTECTOMY 76 0.0066
192 HEREDITARY ANGIOEDEMA 71 0.0066
193 TEMPERATURE INTOLERANCE 68 0.0066
194 BLOOD TESTOSTERONE DECREASED 45 0.0066
195 ANAL INCONTINENCE 59 0.0066
196 FEELING OF BODY TEMPERATURE CHANGE 38 0.0065
197 COMPLICATION OF DEVICE INSERTION 129 0.0065
198 FOOD CRAVING 34 0.0065
199 DEVICE PLACEMENT ISSUE 23 0.0064
200 SPINAL OPERATION 79 0.0064
201 ANKLE FRACTURE 99 0.0064
202 NERVE COMPRESSION 59 0.0064
203 PSYCHOTIC DISORDER 188 0.0064
204 HEAVY MENSTRUAL BLEEDING 57 0.0063
205 MUSCLE TWITCHING 146 0.0063
206 DYSMENORRHOEA 83 0.0063
207 IMPAIRED QUALITY OF LIFE 90 0.0063
208 HYPOMANIA 23 0.0062
209 AFFECT LABILITY 60 0.0062
210 TRIGEMINAL NEURALGIA 25 0.0062
211 SELF-INJURIOUS IDEATION 26 0.0062
212 HALLUCINATION, AUDITORY 98 0.0062
213 UTERINE LEIOMYOMA 45 0.0062
214 OVARIAN CYST 61 0.0061
215 DRUG SCREEN POSITIVE 48 0.0061
216 AUTOIMMUNE DISORDER 59 0.0060
217 ABNORMAL DREAMS 167 0.0060
218 IMPAIRED WORK ABILITY 129 0.0060
219 HEAD INJURY 190 0.0060
220 HYPERSOMNIA 171 0.0060
221 OVERWEIGHT 32 0.0060
222 LIGAMENT RUPTURE 26 0.0059
223 THIRST 105 0.0059
224 MEMORY IMPAIRMENT 804 0.0058
225 INABILITY TO AFFORD MEDICATION 58 0.0058
226 ABNORMAL BEHAVIOUR 231 0.0058
227 BRADYPHRENIA 38 0.0058
228 ARTHROPOD BITE 43 0.0058
229 HYPERPHAGIA 23 0.0058
230 GYNAECOMASTIA 178 0.0057
231 SEBORRHOEA 21 0.0057
232 SOCIAL AVOIDANT BEHAVIOUR 33 0.0057
233 EYE MOVEMENT DISORDER 39 0.0057
234 MICTURITION URGENCY 65 0.0057
235 HOMICIDAL IDEATION 23 0.0057
236 NEURODERMATITIS 21 0.0056
237 HYPERACUSIS 21 0.0056
238 GASTROENTERITIS VIRAL 101 0.0056
239 MENTAL DISORDER 242 0.0056
240 CEREBRAL DISORDER 41 0.0055
241 FOOT FRACTURE 105 0.0055
242 RETCHING 118 0.0055
243 ROTATOR CUFF SYNDROME 71 0.0055
244 WITHDRAWAL SYNDROME 232 0.0055
245 RESTLESSNESS 200 0.0055
246 PRODUCT SUPPLY ISSUE 39 0.0055
247 LIGAMENT SPRAIN 54 0.0055
248 PERONEAL NERVE PALSY 31 0.0055
249 PELVIC PAIN 99 0.0054
250 LIMB INJURY 148 0.0054
251 UTERINE PERFORATION 46 0.0054
252 NIGHTMARE 188 0.0054
253 ENERGY INCREASED 32 0.0054
254 IRRITABLE BOWEL SYNDROME 116 0.0054
255 INFUSION SITE SWELLING 34 0.0054
256 POOR PERIPHERAL CIRCULATION 23 0.0054
257 SLUGGISHNESS 55 0.0054
258 TRIGGER FINGER 22 0.0054
259 ROSACEA 25 0.0054
260 DEPRESSED MOOD 283 0.0053
261 TOOTH FRACTURE 59 0.0053
262 SPINAL OSTEOARTHRITIS 47 0.0053
263 DERMATITIS CONTACT 61 0.0053
264 NIGHT SWEATS 172 0.0053
265 VULVOVAGINAL MYCOTIC INFECTION 21 0.0053
266 PSYCHOMOTOR HYPERACTIVITY 88 0.0053
267 EAR INFECTION 141 0.0053
268 GALACTORRHOEA 34 0.0053
269 BACK DISORDER 86 0.0053
270 DYSPHEMIA 23 0.0052
271 SINUSITIS 537 0.0052
272 TOOTH EXTRACTION 65 0.0052
273 INSOMNIA 1391 0.0052
274 PHARYNGEAL SWELLING 51 0.0052
275 TOOTH ABSCESS 53 0.0052
276 SEXUAL DYSFUNCTION 61 0.0052
277 SINUS DISORDER 103 0.0052
278 INCREASED APPETITE 99 0.0052
279 MOOD ALTERED 141 0.0052
280 BRAIN INJURY 51 0.0051
281 MUSCLE STRAIN 44 0.0051
282 THERAPY CHANGE 50 0.0051
283 ECONOMIC PROBLEM 76 0.0050
284 INCONTINENCE 53 0.0050
285 PANIC REACTION 36 0.0050
286 MULTIPLE ALLERGIES 39 0.0050
287 MUSCLE SPASTICITY 61 0.0050
288 ACTIVITIES OF DAILY LIVING IMPAIRED 98 0.0049
289 PERFORMANCE STATUS DECREASED 23 0.0049
290 MULTIPLE SCLEROSIS 234 0.0049
291 PRODUCT COLOUR ISSUE 25 0.0049
292 SKIN ABRASION 23 0.0049
293 HYPERHIDROSIS 626 0.0049
294 DRUG EFFECT DELAYED 22 0.0048
295 STREPTOCOCCAL INFECTION 27 0.0048
296 OPTIC NEURITIS 44 0.0048
297 THERAPEUTIC PRODUCT EFFECT DELAYED 22 0.0048
298 HAND FRACTURE 34 0.0048
299 ONYCHOMYCOSIS 21 0.0048
300 JOINT INJURY 102 0.0048
301 COGNITIVE DISORDER 222 0.0047
302 DYSPHORIA 24 0.0047
303 UPPER-AIRWAY COUGH SYNDROME 39 0.0047
304 SCREAMING 30 0.0047
305 PRODUCT PHYSICAL ISSUE 95 0.0047
306 INTERVERTEBRAL DISC DISORDER 20 0.0047
307 MULTIPLE SCLEROSIS RELAPSE 321 0.0047
308 ANHEDONIA 123 0.0047
309 ILLNESS 475 0.0046
310 PSYCHIATRIC SYMPTOM 34 0.0046
311 MALABSORPTION 24 0.0046
312 PRODUCT PREPARATION ERROR 93 0.0045
313 COORDINATION ABNORMAL 63 0.0045
314 KIDNEY INFECTION 88 0.0045
315 MENSTRUATION IRREGULAR 120 0.0045
316 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
317 VAGINAL DISCHARGE 45 0.0044
318 CENTRAL NERVOUS SYSTEM LESION 61 0.0044
319 BLOOD PRESSURE INCREASED 678 0.0044
320 PROCEDURAL PAIN 123 0.0044
321 BLADDER DISORDER 44 0.0044
322 OSTEOPENIA 67 0.0044
323 NERVE INJURY 49 0.0044
324 TOOTH INFECTION 58 0.0044
325 SCIATICA 70 0.0044
326 SENSATION OF FOREIGN BODY 37 0.0044
327 BALANCE DISORDER 379 0.0044
328 EXOSTOSIS 40 0.0044
329 ABNORMAL WEIGHT GAIN 54 0.0044
330 HEART RATE INCREASED 433 0.0044
331 HAIR DISORDER 36 0.0044
332 TOOTH DISORDER 97 0.0044
333 AGITATION 320 0.0044
334 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 208 0.0043
335 BLOOD CHOLESTEROL ABNORMAL 20 0.0043
336 INCOHERENT 28 0.0043
337 HYPERPROLACTINAEMIA 28 0.0043
338 DIPLOPIA 112 0.0043
339 PERIPHERAL COLDNESS 59 0.0043
340 INTERMENSTRUAL BLEEDING 24 0.0043
341 FOOD POISONING 23 0.0043
342 URINARY INCONTINENCE 127 0.0043
343 SLEEP DISORDER 302 0.0043
344 INFUSION SITE PAIN 55 0.0043
345 DISORIENTATION 169 0.0043
346 DRY MOUTH 346 0.0043
347 GASTROOESOPHAGEAL REFLUX DISEASE 343 0.0043
348 WRIST FRACTURE 51 0.0043
349 VAGINAL INFECTION 20 0.0042
350 DYSKINESIA 172 0.0042
351 FEELING HOT 259 0.0042
352 IRON DEFICIENCY 19 0.0042
353 APPETITE DISORDER 28 0.0042
354 THYROID DISORDER 65 0.0042
355 PRE-ECLAMPSIA 20 0.0042
356 MENTAL IMPAIRMENT 102 0.0042
357 WEIGHT FLUCTUATION 44 0.0042
358 FORMICATION 29 0.0042
359 THERAPEUTIC RESPONSE SHORTENED 138 0.0042
360 EAR DISORDER 19 0.0041
361 FACIAL PAIN 37 0.0041
362 HYPERVENTILATION 24 0.0041
363 MUSCLE SPASMS 759 0.0041
364 NECK PAIN 231 0.0041
365 TREMOR 686 0.0041
366 MUSCULOSKELETAL DISCOMFORT 71 0.0041
367 HEART RATE ABNORMAL 23 0.0041
368 TENSION 25 0.0041
369 ACCIDENT 49 0.0041
370 RESPIRATION ABNORMAL 28 0.0041
371 SKIN LACERATION 44 0.0040
372 SCAR 69 0.0040
373 AMNESIA 262 0.0040
374 HEPATIC STEATOSIS 75 0.0040
375 LIMB DISCOMFORT 124 0.0040
376 AGGRESSION 200 0.0040
377 EAR DISCOMFORT 41 0.0040
378 DEVICE BREAKAGE 162 0.0040
379 RIB FRACTURE 82 0.0040
380 SENSORY LOSS 32 0.0040
381 COLD SWEAT 70 0.0040
382 VERTIGO 241 0.0040
383 CYST 49 0.0039
384 AMENORRHOEA 69 0.0039
385 BRONCHITIS 290 0.0039
386 URINE ODOUR ABNORMAL 23 0.0039
387 THERAPEUTIC PRODUCT EFFECT DECREASED 175 0.0039
388 PHOTOPHOBIA 73 0.0039
389 HIP SURGERY 21 0.0039
390 JOINT DISLOCATION 41 0.0039
391 TRISMUS 20 0.0039
392 BLOOD PRESSURE ABNORMAL 77 0.0039
393 MENSTRUAL DISORDER 32 0.0039
394 BLOOD CHOLESTEROL INCREASED 180 0.0039
395 WEIGHT INCREASED 862 0.0038
396 NEUROLOGICAL SYMPTOM 22 0.0038
397 POLLAKIURIA 160 0.0038
398 PSYCHOLOGICAL TRAUMA 33 0.0038
399 AUTISM SPECTRUM DISORDER 21 0.0038
400 CHOKING SENSATION 21 0.0038
401 QUALITY OF LIFE DECREASED 51 0.0038
402 METABOLIC DISORDER 22 0.0038
403 LETHARGY 217 0.0038
404 NYSTAGMUS 20 0.0038
405 TREATMENT NONCOMPLIANCE 206 0.0038
406 HYPOTHYROIDISM 120 0.0038
407 PARAESTHESIA ORAL 54 0.0037
408 SENSORY DISTURBANCE 60 0.0037
409 HYPOAESTHESIA 559 0.0037
410 UPPER RESPIRATORY TRACT INFECTION 172 0.0037
411 BREAST TENDERNESS 28 0.0037
412 IMMUNE SYSTEM DISORDER 49 0.0037
413 HEADACHE 2328 0.0037
414 HIATUS HERNIA 48 0.0037
415 WEIGHT DECREASED 1034 0.0037
416 PRESYNCOPE 90 0.0037
417 SINUS CONGESTION 50 0.0037
418 MENSTRUATION DELAYED 40 0.0037
419 FATIGUE 2872 0.0037
420 PALPITATIONS 432 0.0037
421 DELUSION 57 0.0037
422 PARAESTHESIA 575 0.0037
423 HYPERTENSION 774 0.0037
424 TARDIVE DYSKINESIA 103 0.0036
425 ASTHENOPIA 20 0.0036
426 BLOOD IRON DECREASED 43 0.0036
427 DROOLING 25 0.0036
428 CATATONIA 19 0.0036
429 APHASIA 109 0.0036
430 SKIN WARM 21 0.0036
431 SEROTONIN SYNDROME 69 0.0036
432 TINNITUS 165 0.0036
433 CARDIAC MURMUR 31 0.0036
434 INTENTIONAL UNDERDOSE 26 0.0036
435 BLOOD POTASSIUM DECREASED 107 0.0036
436 CARDIAC FLUTTER 23 0.0036
437 THERAPEUTIC RESPONSE DECREASED 215 0.0035
438 SINUS HEADACHE 21 0.0035
439 MOTOR DYSFUNCTION 36 0.0035
440 SEIZURE 408 0.0035
441 FEAR 95 0.0035
442 AKATHISIA 48 0.0035
443 PRODUCT DOSE OMISSION ISSUE 1033 0.0035
444 BEHAVIOUR DISORDER 19 0.0035
445 BLEPHAROSPASM 22 0.0035
446 SPINAL DISORDER 33 0.0035
447 NASOPHARYNGITIS 640 0.0035
448 PREGNANCY WITH CONTRACEPTIVE DEVICE 31 0.0035
449 CONDITION AGGRAVATED 1051 0.0035
450 HALLUCINATION 260 0.0034
451 GENERALISED TONIC-CLONIC SEIZURE 57 0.0034
452 COMPLICATION ASSOCIATED WITH DEVICE 50 0.0034
453 PRODUCT DOSE OMISSION IN ERROR 97 0.0034
454 NERVOUSNESS 178 0.0034
455 DYSARTHRIA 128 0.0034
456 BOWEL MOVEMENT IRREGULARITY 26 0.0034
457 ARTHRITIS 267 0.0034
458 SKIN INFECTION 38 0.0034
459 LOWER LIMB FRACTURE 65 0.0034
460 EXPOSURE DURING PREGNANCY 210 0.0034
461 NAUSEA 2671 0.0034
462 MATERNAL EXPOSURE BEFORE PREGNANCY 23 0.0034
463 HAIR TEXTURE ABNORMAL 45 0.0034
464 DEVICE DISLOCATION 146 0.0034
465 PRODUCT PREPARATION ISSUE 22 0.0034
466 PRODUCT DISTRIBUTION ISSUE 31 0.0033
467 DYSGRAPHIA 22 0.0033
468 COVID-19 584 0.0033
469 LYMPHOEDEMA 23 0.0033
470 FALL 1105 0.0033
471 TONGUE DISORDER 24 0.0033
472 MOUTH SWELLING 19 0.0033
473 THERAPY CESSATION 169 0.0033
474 HEAD DISCOMFORT 58 0.0033
475 UPPER LIMB FRACTURE 65 0.0033
476 TOOTHACHE 59 0.0033
477 DIZZINESS 1623 0.0033
478 DRUG EFFECT DECREASED 175 0.0032
479 EATING DISORDER 69 0.0032
480 LOSS OF CONSCIOUSNESS 415 0.0032
481 SUICIDE ATTEMPT 196 0.0032
482 ABDOMINAL DISCOMFORT 542 0.0032
483 INFUSION SITE EXTRAVASATION 20 0.0032
484 POLYP 21 0.0032
485 PRODUCT QUALITY ISSUE 435 0.0032
486 NASAL DRYNESS 20 0.0032
487 INJURY 224 0.0032
488 RESPIRATORY TRACT INFECTION 83 0.0032
489 HYPOAESTHESIA ORAL 48 0.0032
490 MUSCULAR WEAKNESS 361 0.0032
491 ORAL HERPES 62 0.0032
492 DERMATITIS ATOPIC 167 0.0032
493 MENORRHAGIA 62 0.0032
494 DECREASED ACTIVITY 34 0.0031
495 SPEECH DISORDER 165 0.0031
496 ACNE 238 0.0031
497 STAPHYLOCOCCAL INFECTION 103 0.0031
498 SENSITIVE SKIN 23 0.0031
499 ASTHMA 351 0.0031
500 OSTEOARTHRITIS 131 0.0031
501 POST PROCEDURAL INFECTION 25 0.0031
502 LOCALISED INFECTION 74 0.0031
503 COELIAC DISEASE 30 0.0031
504 FEELING COLD 85 0.0031
505 BEDRIDDEN 40 0.0030
506 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 615 0.0030
507 FURUNCLE 24 0.0030
508 CANDIDA INFECTION 51 0.0030
509 IMMUNODEFICIENCY 45 0.0030
510 HYPERLIPIDAEMIA 36 0.0030
511 HOT FLUSH 225 0.0030
512 HALLUCINATION, VISUAL 63 0.0030
513 EAR PAIN 58 0.0030
514 BACK PAIN 692 0.0030
515 BREAST MASS 20 0.0030
516 HAIR COLOUR CHANGES 37 0.0030
517 CHOKING 58 0.0030
518 INFUSION SITE ERYTHEMA 25 0.0030
519 MUSCLE DISORDER 24 0.0030
520 KNEE ARTHROPLASTY 62 0.0029
521 DYSTONIA 57 0.0029
522 INCREASED TENDENCY TO BRUISE 27 0.0029
523 EYE INFECTION 33 0.0029
524 ERECTILE DYSFUNCTION 75 0.0029
525 CONTUSION 281 0.0029
526 SKIN FISSURES 57 0.0029
527 POST PROCEDURAL COMPLICATION 56 0.0029
528 NEUROPATHY PERIPHERAL 276 0.0029
529 NASAL DISCOMFORT 23 0.0029
530 DISCOMFORT 177 0.0029
531 DIZZINESS POSTURAL 28 0.0029
532 DRY EYE 144 0.0029
533 TENDERNESS 30 0.0029
534 VISION BLURRED 395 0.0029
535 NASAL CONGESTION 168 0.0029
536 DYSPEPSIA 281 0.0029
537 MADAROSIS 33 0.0028
538 MUSCLE ATROPHY 36 0.0028
539 HYPOPHOSPHATAEMIA 21 0.0028
540 MALIGNANT MELANOMA 38 0.0028
541 SKIN HAEMORRHAGE 42 0.0028
542 FACIAL PARALYSIS 24 0.0028
543 BLOOD SODIUM DECREASED 53 0.0028
544 HYPERAESTHESIA 23 0.0028
545 EYE DISCHARGE 29 0.0028
546 OROPHARYNGEAL PAIN 258 0.0028
547 GAIT DISTURBANCE 533 0.0028
548 CONFUSIONAL STATE 450 0.0028
549 BLOOD MAGNESIUM DECREASED 24 0.0028
550 LOSS OF LIBIDO 25 0.0028
551 MOVEMENT DISORDER 89 0.0028
552 RENAL CYST 22 0.0028
553 OCULAR DISCOMFORT 31 0.0028
554 FUNGAL INFECTION 92 0.0028
555 METRORRHAGIA 47 0.0028
556 EMOTIONAL DISTRESS 333 0.0027
557 HERNIA 53 0.0027
558 ANKYLOSING SPONDYLITIS 36 0.0027
559 DEVICE EXPULSION 176 0.0027
560 PAIN 1667 0.0027
561 TENDONITIS 42 0.0027
562 PSORIATIC ARTHROPATHY 110 0.0027
563 INTENTIONAL PRODUCT MISUSE 236 0.0027
564 DISEASE RECURRENCE 128 0.0027
565 DRUG WITHDRAWAL SYNDROME 235 0.0027
566 FLUSHING 272 0.0027
567 TENDON RUPTURE 33 0.0027
568 BLOOD PRESSURE FLUCTUATION 64 0.0027
569 DEHYDRATION 355 0.0027
570 DRY THROAT 27 0.0027
571 ECZEMA 139 0.0027
572 RESPIRATORY TRACT CONGESTION 42 0.0026
573 TENDON PAIN 20 0.0026
574 ULCER 42 0.0026
575 SCHIZOPHRENIA 32 0.0026
576 GALLBLADDER DISORDER 47 0.0026
577 HOSPITALISATION 404 0.0026
578 THROAT TIGHTNESS 71 0.0026
579 BODY HEIGHT DECREASED 28 0.0026
580 BLOOD TRIGLYCERIDES INCREASED 46 0.0026
581 SWELLING 243 0.0026
582 INFLUENZA 288 0.0026
583 DRUG INEFFECTIVE 3403 0.0026
584 APHTHOUS ULCER 20 0.0026
585 GASTROINTESTINAL DISORDER 230 0.0026
586 POLYURIA 21 0.0026
587 INFLUENZA LIKE ILLNESS 211 0.0026
588 VAGINAL HAEMORRHAGE 111 0.0026
589 VOMITING 1199 0.0025
590 RENAL PAIN 27 0.0025
591 OROPHARYNGEAL DISCOMFORT 23 0.0025
592 URINARY TRACT INFECTION 433 0.0025
593 VISUAL IMPAIRMENT 313 0.0025
594 PAROSMIA 19 0.0025
595 PARALYSIS 36 0.0025
596 FEEDING DISORDER 51 0.0025
597 ABDOMINAL DISTENSION 262 0.0025
598 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
599 GROIN PAIN 22 0.0025
600 DRUG USE DISORDER 21 0.0025
601 IRON DEFICIENCY ANAEMIA 23 0.0025
602 DRUG DISPENSING ERROR 38 0.0025
603 CELLULITIS 125 0.0025
604 DECREASED APPETITE 572 0.0025
605 ABDOMINAL PAIN UPPER 506 0.0025
606 GASTROINTESTINAL PAIN 27 0.0025
607 TACHYCARDIA 218 0.0025
608 VITREOUS FLOATERS 24 0.0024
609 HYPERSENSITIVITY 453 0.0024
610 APHONIA 34 0.0024
611 NEOPLASM 28 0.0024
612 PERIPHERAL SWELLING 374 0.0024
613 ABORTION SPONTANEOUS 97 0.0024
614 SKIN SWELLING 21 0.0024
615 PULMONARY MASS 36 0.0024
616 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 41 0.0024
617 HIDRADENITIS 22 0.0024
618 VENTRICULAR EXTRASYSTOLES 25 0.0024
619 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 171 0.0024
620 ALOPECIA 472 0.0024
621 DYSSTASIA 70 0.0024
622 PRODUCT DISPENSING ERROR 52 0.0024
623 PRODUCT ODOUR ABNORMAL 25 0.0024
624 GRIP STRENGTH DECREASED 21 0.0024
625 OESOPHAGITIS 26 0.0024
626 EXTRA DOSE ADMINISTERED 96 0.0024
627 MALAISE 1031 0.0023
628 CONSTIPATION 509 0.0023
629 PNEUMOTHORAX 37 0.0023
630 MUSCULOSKELETAL CHEST PAIN 36 0.0023
631 THERAPY INTERRUPTED 166 0.0023
632 SNEEZING 52 0.0023
633 TOOTH LOSS 48 0.0023
634 CHEST DISCOMFORT 237 0.0023
635 MUSCULOSKELETAL DISORDER 44 0.0023
636 DYSURIA 85 0.0023
637 SPINAL PAIN 27 0.0023
638 UNRESPONSIVE TO STIMULI 59 0.0023
639 HYPERTHYROIDISM 33 0.0023
640 SKIN DISORDER 76 0.0023
641 URINARY RETENTION 76 0.0023
642 INTENTIONAL SELF-INJURY 46 0.0023
643 SCRATCH 24 0.0023
644 ATAXIA 27 0.0023
645 RHINORRHOEA 147 0.0023
646 HYPOKINESIA 33 0.0023
647 DRUG ABUSE 189 0.0023
648 PRODUCT DOSE OMISSION 148 0.0023
649 EYELID PTOSIS 23 0.0023
650 HEART RATE DECREASED 79 0.0022
651 APPENDICITIS 21 0.0022
652 DRUG DOSE OMISSION 371 0.0022
653 INJECTION SITE URTICARIA 55 0.0022
654 PHOTOSENSITIVITY REACTION 37 0.0022
655 DYSPHAGIA 208 0.0022
656 MYDRIASIS 28 0.0022
657 DYSGEUSIA 162 0.0022
658 ADVERSE DRUG REACTION 195 0.0022
659 PRODUCT USE ISSUE 407 0.0022
660 FOOT DEFORMITY 24 0.0022
661 FLUID RETENTION 110 0.0022
662 ORAL DISCOMFORT 30 0.0022
663 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 389 0.0022
664 BREAST PAIN 23 0.0022
665 HYPOPHAGIA 55 0.0021
666 MASS 30 0.0021
667 MUSCULOSKELETAL STIFFNESS 188 0.0021
668 ARTHROPATHY 119 0.0021
669 MYALGIA 364 0.0021
670 GASTRIC DISORDER 73 0.0021
671 THROAT IRRITATION 95 0.0021
672 CYSTITIS 67 0.0021
673 VIRAL INFECTION 70 0.0021
674 EYE SWELLING 78 0.0021
675 JOINT STIFFNESS 55 0.0021
676 GAIT INABILITY 70 0.0021
677 DRUG EFFECT INCOMPLETE 76 0.0021
678 LYMPHADENOPATHY 74 0.0021
679 MUSCLE RIGIDITY 25 0.0021
680 ANOSMIA 30 0.0021
681 HERPES ZOSTER 119 0.0021
682 SKIN DISCOLOURATION 95 0.0021
683 BURSITIS 25 0.0021
684 PRESCRIBED UNDERDOSE 41 0.0021
685 INJECTION SITE MASS 76 0.0021
686 SINUS TACHYCARDIA 29 0.0020
687 EYE PAIN 115 0.0020
688 PAIN IN EXTREMITY 599 0.0020
689 DRY SKIN 271 0.0020
690 HIP ARTHROPLASTY 31 0.0020
691 OSTEOPOROSIS 83 0.0020
692 SWELLING FACE 131 0.0020
693 ORAL PAIN 45 0.0020
694 INJECTION SITE INDURATION 26 0.0020
695 CHILLS 235 0.0020
696 BLOOD PRESSURE DECREASED 133 0.0020
697 HAEMORRHOIDS 39 0.0020
698 SPINAL FRACTURE 40 0.0020
699 SECRETION DISCHARGE 25 0.0020
700 ASTHENIA 749 0.0020
701 BURNING SENSATION 139 0.0020
702 ELECTROLYTE IMBALANCE 23 0.0020
703 MOBILITY DECREASED 142 0.0020
704 GASTRITIS 52 0.0020
705 SYNCOPE 197 0.0020
706 ERUCTATION 38 0.0020
707 INJECTION SITE REACTION 135 0.0020
708 URTICARIA 328 0.0020
709 ARTHRALGIA 811 0.0019
710 CHEST PAIN 361 0.0019
711 DIVERTICULITIS 54 0.0019
712 ABSCESS 31 0.0019
713 HEPATIC ENZYME INCREASED 132 0.0019
714 DYSPHONIA 113 0.0019
715 SCAB 22 0.0019
716 DIABETES MELLITUS 147 0.0019
717 LYMPHOCYTE COUNT DECREASED 34 0.0019
718 SKIN EXFOLIATION 162 0.0019
719 DERMATITIS 40 0.0019
720 BLOOD URINE PRESENT 36 0.0019
721 ADRENAL INSUFFICIENCY 23 0.0019
722 GASTRIC ULCER 36 0.0019
723 INCORRECT PRODUCT ADMINISTRATION DURATION 41 0.0019
724 MUSCULOSKELETAL PAIN 99 0.0019
725 PHARYNGEAL OEDEMA 29 0.0019
726 DEVICE DEPLOYMENT ISSUE 24 0.0019
727 CARDIOMEGALY 23 0.0019
728 GLAUCOMA 36 0.0019
729 CHROMATURIA 42 0.0019
730 SWOLLEN TONGUE 58 0.0019
731 SYSTEMIC LUPUS ERYTHEMATOSUS 65 0.0018
732 COUGH 512 0.0018
733 EYE DISORDER 60 0.0018
734 ABDOMINAL PAIN LOWER 46 0.0018
735 EXPIRED PRODUCT ADMINISTERED 60 0.0018
736 POOR QUALITY PRODUCT ADMINISTERED 19 0.0018
737 PRURITUS 691 0.0018
738 PREGNANCY 36 0.0018
739 DRUG DEPENDENCE 289 0.0018
740 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
741 MALNUTRITION 20 0.0018
742 CLOSTRIDIUM DIFFICILE INFECTION 39 0.0018
743 THERAPY NON-RESPONDER 80 0.0018
744 SKIN ULCER 46 0.0018
745 PRODUCT USE COMPLAINT 28 0.0018
746 PAIN IN JAW 50 0.0018
747 NERVOUS SYSTEM DISORDER 55 0.0018
748 MACULAR DEGENERATION 21 0.0018
749 ORAL CANDIDIASIS 23 0.0017
750 INJECTION SITE SWELLING 133 0.0017
751 PRODUCT ADMINISTRATION ERROR 35 0.0017
752 INJECTION SITE BRUISING 138 0.0017
753 TYPE 2 DIABETES MELLITUS 58 0.0017
754 ANAPHYLACTIC REACTION 95 0.0017
755 RASH MACULAR 60 0.0017
756 TREATMENT FAILURE 142 0.0017
757 SKIN LESION 47 0.0017
758 CHRONIC KIDNEY DISEASE 130 0.0017
759 PRODUCT ADHESION ISSUE 61 0.0017
760 CONTRAINDICATED PRODUCT ADMINISTERED 51 0.0017
761 INCORRECT DOSE ADMINISTERED 384 0.0017
762 HEART RATE IRREGULAR 38 0.0017
763 SKIN IRRITATION 77 0.0017
764 CHOLECYSTITIS 20 0.0017
765 DYSPNOEA 948 0.0017
766 PAIN OF SKIN 45 0.0017
767 EYE IRRITATION 96 0.0017
768 BASAL CELL CARCINOMA 26 0.0017
769 HAEMATOCRIT DECREASED 33 0.0017
770 RASH 724 0.0017
771 OSTEOMYELITIS 30 0.0017
772 DRUG INTOLERANCE 160 0.0017
773 MENTAL STATUS CHANGES 46 0.0017
774 ABDOMINAL PAIN 385 0.0017
775 PRODUCT USE IN UNAPPROVED INDICATION 409 0.0016
776 CHOLELITHIASIS 54 0.0016
777 SKIN BURNING SENSATION 117 0.0016
778 DRUG INTERACTION 259 0.0016
779 RESPIRATORY DEPRESSION 20 0.0016
780 BLINDNESS UNILATERAL 23 0.0016
781 SMALL INTESTINAL OBSTRUCTION 20 0.0016
782 OEDEMA 88 0.0016
783 BONE PAIN 95 0.0016
784 INFECTION 234 0.0016
785 PHARYNGITIS 20 0.0016
786 DEVICE ISSUE 144 0.0016
787 FLATULENCE 91 0.0016
788 WHEEZING 95 0.0016
789 SYRINGE ISSUE 28 0.0016
790 PSORIASIS 208 0.0016
791 LIP SWELLING 53 0.0016
792 NO ADVERSE EVENT 288 0.0016
793 RHEUMATOID ARTHRITIS 180 0.0016
794 MULTIPLE FRACTURES 26 0.0016
795 PALLOR 43 0.0016
796 INJECTION SITE PAIN 480 0.0016
797 EPISTAXIS 117 0.0016
798 RASH PAPULAR 35 0.0016
799 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 111 0.0016
800 LACRIMATION INCREASED 47 0.0016
801 ORTHOSTATIC HYPOTENSION 27 0.0015
802 INFLAMMATION 80 0.0015
803 INJECTION SITE PRURITUS 103 0.0015
804 MATERNAL EXPOSURE DURING PREGNANCY 137 0.0015
805 PLATELET COUNT INCREASED 20 0.0015
806 THROMBOSIS 123 0.0015
807 RENAL DISORDER 71 0.0015
808 IMPAIRED HEALING 50 0.0015
809 BODY TEMPERATURE INCREASED 31 0.0015
810 EYE PRURITUS 51 0.0015
811 DIARRHOEA 978 0.0015
812 PRODUCT PRESCRIBING ISSUE 33 0.0015
813 JOINT SWELLING 182 0.0015
814 BACTERIAL INFECTION 28 0.0015
815 CATARACT 89 0.0015
816 AGEUSIA 37 0.0015
817 BONE DISORDER 27 0.0015
818 TASTE DISORDER 30 0.0015
819 BLISTER 83 0.0015
820 GENITAL HAEMORRHAGE 19 0.0015
821 GLOSSODYNIA 33 0.0015
822 PRODUCT PRESCRIBING ERROR 35 0.0015
823 GINGIVAL BLEEDING 20 0.0015
824 CYANOSIS 23 0.0015
825 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76 0.0015
826 ADVERSE EVENT 134 0.0015
827 LIVER FUNCTION TEST INCREASED 31 0.0014
828 RED BLOOD CELL COUNT DECREASED 41 0.0014
829 ADVERSE REACTION 19 0.0014
830 INTESTINAL OBSTRUCTION 54 0.0014
831 EXPOSURE VIA SKIN CONTACT 37 0.0014
832 OFF LABEL USE 1250 0.0014
833 HEMIPARESIS 24 0.0014
834 UNDERDOSE 103 0.0014
835 INJECTION SITE RASH 43 0.0014
836 ERYTHEMA 287 0.0014
837 LEUKOCYTOSIS 25 0.0014
838 WHITE BLOOD CELL COUNT INCREASED 53 0.0014
839 PRODUCT COMPLAINT 35 0.0014
840 DEAFNESS 36 0.0014
841 MOUTH ULCERATION 29 0.0014
842 LOCAL SWELLING 24 0.0014
843 DEEP VEIN THROMBOSIS 89 0.0014
844 DEPRESSED LEVEL OF CONSCIOUSNESS 54 0.0014
845 INJECTION SITE ERYTHEMA 169 0.0014
846 PRODUCTIVE COUGH 65 0.0014
847 RASH ERYTHEMATOUS 65 0.0014
848 STOMATITIS 82 0.0014
849 BLINDNESS 55 0.0013
850 WRONG TECHNIQUE IN DRUG USAGE PROCESS 49 0.0013
851 OCULAR HYPERAEMIA 64 0.0013
852 BRONCHOSPASM 19 0.0013
853 INTENTIONAL OVERDOSE 85 0.0013
854 APPLICATION SITE PAIN 29 0.0013
855 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 24 0.0013
856 NEEDLE ISSUE 38 0.0013
857 TRANSIENT ISCHAEMIC ATTACK 44 0.0013
858 BLOOD GLUCOSE ABNORMAL 24 0.0013
859 LUNG INFECTION 20 0.0013
860 HAEMATOCHEZIA 71 0.0013
861 PNEUMONIA 416 0.0013
862 ACCIDENTAL OVERDOSE 47 0.0013
863 ILL-DEFINED DISORDER 78 0.0013
864 INFUSION RELATED REACTION 85 0.0013
865 HYPOKALAEMIA 59 0.0013
866 EPILEPSY 39 0.0013
867 COLITIS ULCERATIVE 57 0.0013
868 RESPIRATORY DISORDER 38 0.0013
869 DEVICE DEFECTIVE 22 0.0013
870 BONE LOSS 19 0.0013
871 HAEMATEMESIS 32 0.0013
872 PREMATURE DELIVERY 20 0.0013
873 GOUT 22 0.0012
874 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 67 0.0012
875 PULMONARY EMBOLISM 116 0.0012
876 OVERDOSE 262 0.0012
877 COLITIS 46 0.0012
878 DRUG ADMINISTRATION ERROR 37 0.0012
879 GLYCOSYLATED HAEMOGLOBIN INCREASED 30 0.0012
880 PYREXIA 411 0.0012
881 LABORATORY TEST ABNORMAL 35 0.0012
882 HYPOACUSIS 51 0.0012
883 LIVER INJURY 29 0.0012
884 INJECTION SITE WARMTH 24 0.0012
885 BLOOD GLUCOSE DECREASED 56 0.0012
886 RASH PRURITIC 63 0.0012
887 DRUG PRESCRIBING ERROR 22 0.0011
888 WOUND 32 0.0011
889 DEVICE USE ISSUE 20 0.0011
890 DEVICE MALFUNCTION 80 0.0011
891 ANAPHYLACTIC SHOCK 29 0.0011
892 SKIN CANCER 24 0.0011
893 VISUAL ACUITY REDUCED 37 0.0011
894 HAEMOPTYSIS 31 0.0011
895 FREQUENT BOWEL MOVEMENTS 30 0.0011
896 INCORRECT DRUG ADMINISTRATION DURATION 31 0.0011
897 CARDIAC DISORDER 103 0.0011
898 DELIRIUM 38 0.0011
899 INJECTION SITE HAEMORRHAGE 87 0.0011
900 HIP FRACTURE 35 0.0011
901 EXTRAPYRAMIDAL DISORDER 27 0.0011
902 HAEMORRHAGE 113 0.0011
903 CONJUNCTIVITIS 20 0.0011
904 FRACTURE 20 0.0011
905 ACUTE RESPIRATORY FAILURE 20 0.0010
906 STEVENS-JOHNSON SYNDROME 23 0.0010
907 INCORRECT DOSE ADMINISTERED BY DEVICE 27 0.0010
908 PRURITUS GENERALISED 22 0.0010
909 HEPATITIS 26 0.0010
910 SEPSIS 113 0.0010
911 ACCIDENTAL EXPOSURE TO PRODUCT 103 0.0010
912 HYPOXIA 35 0.0010
913 ATRIAL FIBRILLATION 96 0.0010
914 OEDEMA PERIPHERAL 120 0.0010
915 DYSPNOEA EXERTIONAL 37 0.0010
916 ABASIA 24 0.0010
917 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
918 DEVICE LEAKAGE 42 0.0010
919 RECTAL HAEMORRHAGE 41 0.0010
920 PANCREATITIS 50 0.0009
921 OXYGEN SATURATION DECREASED 53 0.0009
922 ANAEMIA 179 0.0009
923 INJURY ASSOCIATED WITH DEVICE 19 0.0009
924 APPLICATION SITE PRURITUS 21 0.0009
925 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
926 APPLICATION SITE ERYTHEMA 24 0.0009
927 INTENTIONAL DRUG MISUSE 19 0.0009
928 ARRHYTHMIA 43 0.0009
929 COMA 43 0.0009
930 DEMENTIA 25 0.0009
931 HAEMATOMA 23 0.0009
932 HYPOTENSION 177 0.0009
933 HYPOGLYCAEMIA 42 0.0009
934 HYPERGLYCAEMIA 31 0.0008
935 RASH GENERALISED 22 0.0008
936 LIVER DISORDER 37 0.0008
937 WHITE BLOOD CELL COUNT DECREASED 90 0.0008
938 MEDICATION ERROR 45 0.0008
939 ANGINA PECTORIS 23 0.0008
940 BLOOD CREATININE INCREASED 52 0.0008
941 CEREBROVASCULAR ACCIDENT 131 0.0008
942 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
943 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
944 RESPIRATORY ARREST 21 0.0008
945 PNEUMONIA ASPIRATION 19 0.0008
946 LUNG DISORDER 37 0.0008
947 RENAL FAILURE 100 0.0008
948 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
949 ACUTE MYOCARDIAL INFARCTION 22 0.0007
950 GENERAL PHYSICAL HEALTH DETERIORATION 86 0.0007
951 NEUTROPHIL COUNT DECREASED 30 0.0007
952 DRUG DOSE OMISSION BY DEVICE 56 0.0007
953 BLOOD GLUCOSE INCREASED 134 0.0007
954 RENAL IMPAIRMENT 59 0.0007
955 BONE DENSITY DECREASED 22 0.0007
956 RHABDOMYOLYSIS 29 0.0007
957 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
958 FEMUR FRACTURE 21 0.0007
959 HAEMOGLOBIN DECREASED 69 0.0007
960 PRODUCT STORAGE ERROR 58 0.0007
961 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
962 MYOCARDIAL INFARCTION 110 0.0006
963 ACUTE KIDNEY INJURY 93 0.0006
964 BREAST CANCER 55 0.0006
965 HAEMATURIA 20 0.0006
966 PLATELET COUNT DECREASED 62 0.0006
967 DEVICE USE ERROR 20 0.0006
968 CARDIAC ARREST 47 0.0006
969 FOETAL EXPOSURE DURING PREGNANCY 46 0.0006
970 RESPIRATORY FAILURE 41 0.0006
971 CONVULSION 32 0.0006
972 TOXICITY TO VARIOUS AGENTS 91 0.0005
973 NEOPLASM MALIGNANT 35 0.0005
974 CARDIAC FAILURE CONGESTIVE 42 0.0005
975 LUNG NEOPLASM MALIGNANT 21 0.0005
976 SEPTIC SHOCK 22 0.0005
977 DEVICE DIFFICULT TO USE 33 0.0005
978 BRADYCARDIA 26 0.0005
979 PULMONARY OEDEMA 21 0.0005
980 GASTROINTESTINAL HAEMORRHAGE 38 0.0005
981 COMPLETED SUICIDE 37 0.0004
982 HYPONATRAEMIA 25 0.0004
983 PLEURAL EFFUSION 26 0.0004
984 DEPENDENCE 19 0.0003
985 DISEASE PROGRESSION 41 0.0003
986 DEATH 206 0.0002
987 THROMBOCYTOPENIA 24 0.0002
988 MALIGNANT NEOPLASM PROGRESSION 21 0.0002